Early lab results show that ZB131 could reduce growth and even kill multiple types of cancer cells, including ovarian, pancreatic, lung and colorectal. The new funding will go toward manufacturing and testing the drug in human clinical trials.
The University has grown its research funding base more than 32% in five years as it expands the diversity of its research programs and widens the range of sources.
Kara Fitzgibbon, the new director of the Center for Survey Research at UVA’s Weldon Cooper Center for Public Service, says she wants to focus on projects that can improve the community.
In the last two decades, the number of jobs in the hospitality and tourism sector within the state of Virginia has increased by 36%, according to Kyaw Khine of UVA’s Weldon Cooper Center for Public Service.
The Chemical Engineering building and Wilsdorf Hall are home base for the study of catalysis, biotechnology and nanotechnology, and other critical applied research at UVA.